Last updated on March 2018

Patients are needed to participate in a clinical research study for the treatment of Non-Small Cell Lung Cancer

Brief description of study

The purpose of this study is to determine how beta-glucan affects the immune system in subjects with non-small cell lung cancer.

Detailed Study Description

Beta-glucan (Imucell WGP) is an over-the-counter dietary supplement that enhances the body's immune system. Imucell WGP is extracted from food-grade baker's yeast, which is permitted for use in food by the U.S. Food and Drug Administration (FDA). Studies in animals have shown that Imucell WGP helps trigger white blood cells to destroy cancer cells. Other animal studies combining Imucell WGP with anti-cancer medications have shown greater tumor regression and tumor-free survival.

Clinical Study Identifier: NCT00682032

Find a site near you

Start Over

James Graham Brown Cancer Center

Louisville, KY United States
  Connect »